These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. Vicino A; Hottinger AF; Latifyan S; Boughdad S; Becce F; Prior JO; Kuntzer T; Brouland JP; Dunet V; Obeid M; Théaudin M J Neurol; 2024 Apr; 271(4):1947-1958. PubMed ID: 38141128 [TBL] [Abstract][Full Text] [Related]
63. [Immune checkpoint inhibitor-induced anti-striational antibodies in myasthenia gravis and myositis: a case report]. Sugiyama Y; Esa Y; Watanabe A; Kobayashi J; Suzuki S; Takahashi D Rinsho Shinkeigaku; 2021 Sep; 61(9):630-634. PubMed ID: 34433744 [TBL] [Abstract][Full Text] [Related]
64. Pembrolizumab-induced peripheral nervous system damage: A combination of myositis/ myasthenia overlap syndrome and motor axonal polyneuropathy. Arman Ç; Ibrahim K; Elif OK; Hacer D; Yeşim P Ideggyogy Sz; 2023 Nov; 76(11-12):422-426. PubMed ID: 38051685 [TBL] [Abstract][Full Text] [Related]
65. Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience. Diamanti L; Picca A; Bini P; Gastaldi M; Alfonsi E; Pichiecchio A; Rota E; Rudà R; Bruno F; Villani V; Galiè E; Vogrig A; Valente M; Zoccarato M; Poretto V; Giometto B; Cimminiello C; Del Vecchio M; Marchioni E Neurol Sci; 2022 Mar; 43(3):2031-2041. PubMed ID: 34424427 [TBL] [Abstract][Full Text] [Related]
66. Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review. Bai J; Li D; Yang P; Xu K; Wang Y; Li Q; Liu J; Du W; Zhang F; Feng R Front Oncol; 2021; 11():778185. PubMed ID: 35047395 [TBL] [Abstract][Full Text] [Related]
67. Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report. Zhou Z; Chen X; Liu G; Pu J; Wu J Front Neurol; 2019; 10():770. PubMed ID: 31379720 [TBL] [Abstract][Full Text] [Related]
68. Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia. Takamatsu K; Nakane S; Suzuki S; Kosaka T; Fukushima S; Kimura T; Miyashita A; Mukaino A; Yamakawa S; Watanabe K; Jinnin M; Komohara Y; Ihn H; Ando Y Ann Clin Transl Neurol; 2018 Nov; 5(11):1421-1427. PubMed ID: 30480036 [TBL] [Abstract][Full Text] [Related]
69. Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome. Byer SH; Stewart C; Mansour S; Grewal US Eur J Cancer; 2024 May; 202():114027. PubMed ID: 38507971 [No Abstract] [Full Text] [Related]
70. Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis. Cautela J; Zeriouh S; Gaubert M; Bonello L; Laine M; Peyrol M; Paganelli F; Lalevee N; Barlesi F; Thuny F J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298621 [TBL] [Abstract][Full Text] [Related]
71. Case Report: Orbital Myositis and Myasthenia Gravis as Symptoms of Immune Reconstitution Inflammatory Syndrome in a Patient With Human Immunodeficiency Virus Infection. Wang Y; Zhao N; Yang J; Wen Y Front Immunol; 2020; 11():595068. PubMed ID: 33381117 [TBL] [Abstract][Full Text] [Related]
72. Sintilimab-Induced Myocarditis Overlapping Myositis in a Patient With Metastatic Thymoma: A Case Report. Yang ZX; Chen X; Tang SQ; Zhang Q Front Cardiovasc Med; 2021; 8():797009. PubMed ID: 35004910 [TBL] [Abstract][Full Text] [Related]
73. Immune checkpoint inhibitor-mediated myasthenia gravis with focal subclinical myocarditis progressing to symptomatic cardiac disease. Leaver PJ; Jang HS; Vernon ST; Fernando SL BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32404371 [TBL] [Abstract][Full Text] [Related]